![](https://www.pdfsearch.io/img/7ab719fad6a9a74c9893d3571d2d4032.jpg)
| | Pre-Exposure Prophylaxis (PrEP): A primer for primary care providers Daily emtricitabine/tenofovir (Truvada®) is safe and effective for reducing the risk of HIV acquisition in sexually active men and women and injectionAdd to Reading ListSource URL: www.sfcityclinic.orgDownload Document from Source Website File Size: 359,31 KBShare Document on Facebook
|